Genetic Insights and Pharmacogenomic Approaches in Cancer Treatment
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 March 2026 | Viewed by 551
Special Issue Editor
Special Issue Information
Dear Colleagues,
This Special Issue is focused on “Genetic Insights and Pharmacogenomic Approaches in Cancer Treatment”. Pharmacogenomic approaches have emerged as a powerful tool in cancer treatment, allowing for the optimization of drug therapies based on an individual's genetic makeup. The study of both pharmacology and genomics will predict how a patient will respond to specific medications, helping to maximize treatment efficacy while minimizing adverse effects. In cancer care, pharmacogenomics can guide the selection of chemotherapy drugs, determine appropriate dosages, and identify patients who are likely to experience severe side effects from certain treatments. This personalized approach not only improves patient outcomes but also reduces healthcare costs by avoiding ineffective or potentially harmful treatments. Additionally, pharmacogenomic research is continually uncovering new drug targets and biomarkers, accelerating the development of innovative cancer therapies and bringing us closer to the goal of precision medicine in oncology.
Pharmacogenomics has made significant progress over the last 20 years and is increasingly used in personalized cancer medicine. As the field continues to evolve, the multidisciplinary model of genetic cancer risk assessment and management will serve as a foundation for integrating personalized genomic information into cancer medicine. This Special Issue aims to publish papers related to the genetic basis for interindividual differences in drug response, efficacy, survival, and toxicity in cancer treatments and in providing better and faster diagnosis and prognosis. Both germline and acquired genetic variation are very important to be considered as predictors of response to chemotherapy and targeted therapies and to contribute towards personalized medicine.
Dr. Ana Fernández-Santander
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmacogenetics
- genetic basis
- cancer treatments
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
